InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Lee Jacks. Director active across 2 companies, notably G1 Therapeutics, Inc.. In total, 5 reports have been published. Activity tracked since 15 June 2023. The latest transaction was disclosed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Lee Jacks is a declarant linked to G1 Therapeutics, Inc. and Vaxcyte, Inc., where he is a director. He has 4 filings in total, and across the 4 most recent filings we hold, the period runs from 2023-06-16 to 2024-09-18, with a modal transaction nature of Attribution.